Refractory Status Epilepticus
Authors:
- Isabelle BeuchatIBIsabelle Beuchat
- Felix RosenowFelix Rosenow
- Christoph KellinghausCKChristoph Kellinghaus
- Eugen TrinkaETEugen Trinka
- Iris UnterbergerIUIris Unterberger
- Stephan RüeggSRStephan Rüegg
- Raoul SutterRSRaoul Sutter
- Christian TilzCTChristian Tilz
- Zeljko UzelacZUZeljko Uzelac
- Andrea O. RossettiARAndrea O. Rossetti
- Adam StrzelczykASAdam Strzelczyk
- 18 October 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 99 (16) , E1824-E1834
Abstract
Background and objectives: Refractory status epilepticus (RSE) bear significant morbidity and mortality. Therapy escalation and in some cases intubation are recommended. Most existing studies are retrospective and focus on ICUs. We aimed to describe routine-care management, and analyze determinants of RSE development and outcomes in a large multicenter cohort. Methods: We performed post hoc analysis of an observational, cohort study, who prospectively registered all consecutive adults with SE at 9 centers from 3 German-speaking countries. Only incident episodes were included. Ongoing SE despite 2 anti-seizure medications was defined as RSE. Patients intubated during first- or second-line treatments were excluded. Variables investigated included demographics, severity (Status Epilepticus Severity Score), etiology, and guideline-compliant treatment (defined as fixed minimum doses). Outcome parameters included survival and mRS at baseline and discharge (good: 0–2 or absence of worsening compared with pre-hospitalization). Results: Among 1179 SE episodes from 1049 adults, 996 patients were eligible (median age: 70 years, 52% female), of which 545 (54.7%) developed RSE. RSE was associated with higher baseline mRS (p<0.001) and treatment deviation from guidelines (p<0.001, OR 0.09; 95%CI 0.06-0.1). Good outcomes were observed in 52.7% of refractory patients, correlating with lower status epilepticus severity (p<0.001), absence of acute etiology (p<0.001, OR 0.5 95%CI 0.3-0.7), adequate first-line benzodiazepine dose (p<0.001, OR 2.5 95%CI 1.6-4.0), shorter durations of SE and hospitalization (both p<0.001), and lack of intubation (p<0.001, OR 0.4 95%CI 0.3-0.6). Most (71.7%) refractory patients were not intubated. Intubation was associated with younger age (p=0.006), more severe consciousness disturbances (p<0.001, OR 3.2 95%CI 2.1-4.8), more severe SE types (p<0.001), higher severity score (p=0.009), acute etiologies (p=0.01, OR 1.6 95%CI 1.1-2.4), more anti-seizure medications (p<0.001), initial treatment after shorter latency (p=0.01), worse outcomes (p<0.001, OR 0.4 95%CI 0.4-0.6), and longer hospitalizations (p<0.001). Discussion: Variables associated with RSE were identified, some potentially preventable. More than 70% of RSE were treated without intubation, suggesting that focal RSE without deep impairment of consciousness, in older patients, may be successfully treated outside ICUs. Trial Registration: Original cohort study registered at the German Clinical Trials Register (DRKS00000725).Keywords
This publication has 49 references indexed in Scilit:
- Unified EEG terminology and criteria for nonconvulsive status epilepticusEpilepsia, 2013
- Mortality and recovery from refractory status epilepticus in the intensive care unit: A 7‐year observational studyEpilepsia, 2013
- Third-line antiepileptic therapy and outcome in status epilepticusCritical Care Medicine, 2012
- Guidelines for the Evaluation and Management of Status EpilepticusNeurocritical Care, 2012
- Frequency and Prognosis of Convulsive Status Epilepticus of Different CausesArchives of Neurology, 2010
- Refractory status epilepticus: A prospective observational studyEpilepsia, 2010
- Status Epilepticus Severity Score (STESS)Journal of Neurology, 2008
- Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentationJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unitJournal of Neurology, Neurosurgery & Psychiatry, 2005
- A Comparison of Four Treatments for Generalized Convulsive Status EpilepticusNew England Journal of Medicine, 1998